Healthcare & Life Sciences
Eloxx Pharmaceuticals
United Stateseloxxpharma.com
Eloxx Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2014
Founded
2
Investors
About Eloxx Pharmaceuticals
Based in the United States, Eloxx Pharmaceuticals is a startup founded in 2014. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Eloxx Pharmaceuticals develops small molecule genetic therapies targeting nonsense mutations for rare genetic diseases such as Alport Syndrome, using proprietary platform technologies including TURBO-ZM™ and Ribosome Modulating Agents.
Explore Eloxx Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.